Categories Consumer, Earnings

PepsiCo’s (PEP) Q4 results beat expectations

PepsiCo Inc. (NASDAQ: PEP) topped analysts’ expectations for revenue and earnings in the fourth quarter of 2019. Shares were up slightly in premarket hours on Thursday.  

Total revenue of $20.6 billion was up 5.7% from the same period last year and ahead of consensus estimates of $20.2 billion. On an organic basis, revenues grew 4.3%.  

PepsiCo topped Q4 2019 revenue and earnings expectations

On a GAAP basis, net income was $1.76 billion, or $1.26 per share, compared to $6.8 billion, or $4.83 per share, in the prior year period. Last quarter’s results included a one-time benefit from income taxes of $4.9 billion. Core EPS was $1.45, slightly above forecasts of $1.44.

During the quarter, the company saw revenue increases across all its segments and geographies both on a reported and organic basis, with the exception of the Quaker Foods North America division where revenues remained flat.  

Also read: PepsiCo Q4 2019 Earnings Preview

For fiscal year 2020, organic revenue growth is expected to be 4%. Core constant currency EPS is expected to increase by 7%. Core EPS is estimated to increase by 6% to $5.88.

PepsiCo declared a 7% increase in its annualized dividend to $4.09 per share, effective with the dividend expected to be paid in June 2020.  

The Frito-Lay business has been growing value share in the salty, savory and micro snack categories. The investments being made in marketing and product innovation are paying off with strong revenue growth in large brands such as Doritos, Cheetos and Fritos. The beverages division has benefited from strong growth in Gatorade and Bubly.  

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top